The HeartStart AEDs in question, HeartStart FRx, HeartStart HS1 Home and HeartStart HS1 OnSite, were manufactured between 2005 and 2012. Philips Healthcare previously recalled these AEDs in September 2012 due to a failing internal electrical component. On Nov. 19, 2013, Philips Healthcare issued a Medical Device Safety Notice saying the failure of the electrical component could cause the AED to fail to deliver an appropriate shock.
The FDA recommends healthcare providers using recalled HeartStart AEDs should keep them in service until getting new ones, as there is more of a benefit in attempting to use the AED than not using one at all.
More Articles on the U.S. Food and Drug Administration:
Drug Quality and Security Act Regulates Compounding, Enhances Supply Chain Security
FDA Approves BioMedical Enterprises’ Upgrade to HammerLock Intramedullary Fixation System
FDA Recalls Spacelabs Healthcare’s Anesthesia Workstations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.